Sebaceous Glands

Dr. Sarah Chen
PhD, Molecular Biology
Sebaceous glands are microscopic, lipid-producing organs embedded in the dermis of the skin. They are found across nearly the entire body surface — most densely on the face, scalp, and upper chest — and are typically associated with hair follicles, forming what is known as the pilosebaceous unit . The primary function of sebaceous glands is to synthesize and secrete sebum, a complex lipid mixture that coats the skin surface and plays essential roles in barrier protection, hydration, and innate immunity.
Structure and Function
Sebaceous glands are holocrine glands, meaning that entire cells rupture and disintegrate to release their lipid contents. Sebocytes (the specialized cells of the gland) accumulate lipid droplets as they mature, eventually bursting to deliver sebum into the hair follicle canal and onto the skin surface .
Sebum composition includes:
- Triglycerides and fatty acids (~57%) — Broken down by skin bacteria into free fatty acids, some of which have antimicrobial properties
- Wax esters (~26%) — Unique to human sebum; contribute to the skin's water-repellent surface film
- Squalene (~12%) — An antioxidant lipid that protects against UV-induced oxidative damage
- Cholesterol and cholesterol esters (~5%) — Structural lipids that support skin barrier function
This lipid film forms a critical component of the acid mantle — a slightly acidic layer (pH ~5.5) on the skin surface that discourages pathogenic bacterial colonization and helps maintain the skin barrier .
Regulation of Sebum Production
Sebaceous gland activity is under hormonal and inflammatory control :
- Androgens — Testosterone and its more potent derivative dihydrotestosterone (DHT) are the primary drivers of sebum production. Androgen receptors on sebocytes stimulate gland enlargement and lipid synthesis, which is why sebum output peaks during puberty and contributes to adolescent acne.
- Estrogens — Counterbalance androgen effects by suppressing sebaceous gland activity, which is why acne often improves with estrogen-containing oral contraceptives.
- Peroxisome proliferator-activated receptors (PPARs) — Nuclear receptors that regulate lipid metabolism within sebocytes. PPAR-γ activation promotes sebocyte differentiation and lipid production .
- Inflammatory signaling — Pro-inflammatory cytokines such as IL-1α and TNF-α can alter sebum composition and stimulate sebocyte proliferation, contributing to the inflammatory component of acne .
Sebaceous Glands and Skin Conditions
Acne
Acne vulgaris begins in the pilosebaceous unit. Excess sebum production, combined with abnormal keratinocyte desquamation within the follicle, creates a microcomedo — a plugged follicle. This anaerobic environment fosters Cutibacterium acnes proliferation, which triggers an inflammatory cascade involving IL-1, IL-8, and TNF-α . Altered sebum composition — particularly increased squalene oxidation and reduced linoleic acid — further amplifies inflammation and impairs the follicular barrier.
Sebaceous Gland Aging
With age, sebaceous gland output declines, contributing to the dryness, barrier fragility, and reduced antimicrobial defense seen in aging skin. Decreased sebum production reduces the skin's natural emollient layer and compromises the acid mantle, making aging skin more susceptible to irritation and transepidermal water loss .
Connection to PDRN
While PDRN does not directly target sebaceous glands, its effects on the surrounding dermal environment are relevant to sebaceous gland health :
- Anti-inflammatory effects — PDRN's suppression of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) via the adenosine A2A receptor reduces the inflammatory milieu that drives acne pathogenesis. By lowering the inflammatory burden in the pilosebaceous unit, PDRN may help mitigate inflammatory acne lesions.
- Dermal matrix support — PDRN stimulates fibroblast proliferation and collagen synthesis, improving the structural integrity of the dermis that supports sebaceous glands. Healthier dermal scaffolding contributes to normalized gland function.
- Post-procedure recovery — After acne treatments such as laser therapy or chemical peels, PDRN accelerates wound healing and reduces scarring in areas rich in sebaceous glands (face, chest, back) .
- Barrier restoration — By promoting overall skin barrier recovery, PDRN complements the protective functions of sebum, especially in aging skin where sebum output has declined.
Key Takeaway
Sebaceous glands are essential lipid-producing structures that maintain skin hydration, barrier integrity, and antimicrobial defense through sebum secretion. Their dysregulation — either overproduction in acne or decline with aging — has significant consequences for skin health. PDRN supports the broader dermal environment in which sebaceous glands operate, particularly through its anti-inflammatory effects and promotion of tissue repair .
Related Concepts
- Skin Barrier Function — How sebum contributes to the skin's protective barrier
- Cytokines — Inflammatory mediators that influence sebaceous gland activity
- Wound Healing — Post-procedural recovery in sebaceous gland-rich areas
- Polydeoxyribonucleotide — Full overview of PDRN's mechanism of action
References
- [1]Zouboulis CC, Jourdan E, Picardo M. Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions. Journal of the European Academy of Dermatology and Venereology. 2014;28(5):527-532. doi:10.1111/jdv.12298
- [2]Makrantonaki E, Zouboulis CC. Testosterone metabolism to 5α-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes. British Journal of Dermatology. 2007;156(3):428-432. doi:10.1111/j.1365-2133.2006.07671.x
- [3]Smith KR, Thiboutot DM. Sebaceous gland lipids: friend or foe?. Journal of Lipid Research. 2008;49(2):271-281. doi:10.1194/jlr.R700015-JLR200
- [4]Colangelo MT, Galli C, Gentile P. Polydeoxyribonucleotide: A Promising Biological Platform for Dermal Regeneration. Current Pharmaceutical Design. 2020;26(17):2049-2056. doi:10.2174/1381612826666200210100726